Digital PCR Market Size, Share, and COVID-19 Impact Analysis, By Type (Droplet Digital PCR, Chip-based Digital PCR, Others), By Product (Software and Services, Instruments, Reagents & Consumables), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Research Laboratories and Academic Institutes, Diagnostic Centers, and Clinical Research Organizations & Forensic Laboratories), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) Analysis and Forecast 2022-2030
KEY MARKET INSIGHTS
The Digital PCR Market was valued at USD 250.9 Million in 2021. The market is projected to grow USD 935.3 Million in 2030, at a CAGR of 7.4%. Digital PCR (dPCR) allows for absolute quantification by partitioning the reaction, enabling highly sensitive nucleic acid quantification. This method has proven applications in molecular detection that include copy number variation, uncommon mutation identification, and trace DNA detection. Traditional PCR uses agarose gel electrophoresis to detect the amplified product, making it a semi-quantitative end-point examination. As the reaction develops, real-time PCR (also known as qPCR) uses fluorescence-based detection to enable the measurement of accumulated amplified products.
COVID-19 ANALYSIS
The COVID-19 pandemic is projected to positively affect the growth of the digital PCR market. The tests are utilised to diagnose COVID-19 infection, Additionally, the digital PCR market is expected to rise as there are more facilities specifically designed for COVID-19 diagnostics. The PCR market has experienced a boom, and the diagnostics industry was most severely affected. Real-time and digital PCR are in high demand since they are used for drug research and diagnostic purposes. It is becoming increasingly important for industry entities to test for COVID-19 by creating droplet kits. The regulatory agencies have given these tests their full support in order to limit the COVID-19 pandemic's effects. For instance, Bio-Rad Laboratories received Emergency Use Authorization by the US FDA for Droplet Digital PCR SARS-CoV-2 Test Kit which runs on Bio-Rad's QX200 and QXDx ddPCR systems.
Increasing Preference to Chip-based Digital PCR Supporting the Market Growth
The development of dPCR technology has been majorly aided by the switch from droplet to chip-based for the diagnosis of many diseases. Because the droplets in commercially available droplet dPCR must be manually transferred, the goals are overestimated. Additionally, there is a chance of cross-contamination while using these kits to transfer the sample. On the other hand, droplets always flow in channels in chip-based digital polymerase chain reactions, lowering the possibility of cross-contamination. The usage of this innovation for the detection of various ailments is anticipated to rise in the near future.
Increasing Adoption of Digital PCR Across Different Applications Driving the Market
Increasing dPCR aids to offer an accurate measurement of the target nucleic acid molecules. Researchers are also able to accurately identify tiny mutations and quantify smaller variations because of the consistency, sensitivity, and precision afforded by this absolute DNA quantification. These benefits are driving dPCR use over conventional and other PCR methods, which is anticipated to fuel the expansion of the digital PCR market over the forecast period.
Increasing R&D Activities for Technological Advancement Aiding Market Growth
The development of the digital PCR business is boosted by the increase in R&D activities for PCR technology enhancement and in company partnership agreements. For instance, in January 2022, Qiagen, a well-known manufacturer of diagnostic tools, collaborated with Atila BioSystems and Actome GmbH to offer non-invasive prenatal testing (NIPT) options for QIAGEN's dPCR and licence & co-marketing agreement.
High Costs of dPCR Devices Hampering the Market Growth
The inflated price of these devices further prevents them from being widely adopted. However, actions done by major companies to raise consumer awareness of the use of dPCR for disease diagnosis. The high cost of digital PCR equipment and problems with reimbursement for such equipment limit the market's expansion.
SEGMENTATION INSIGHT
Based on the type, the digital PCR market is categorized droplet digital PCR, chip-based digital PCR and others. Based on product, the market is categorized into software and services, instruments, reagents & consumables. Based on end user, the digital PCR market is categorized into hospitals & clinics, pharmaceutical & biotechnology industries, research laboratories and academic institutes, diagnostic centers, and clinical research organizations and forensic laboratories. Based on the region, the market is categorized into North America, Europe, Asia-Pacific, South America, Middle East and Africa.
REGIONAL INSIGHTS
The global digital PCR market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
North America region is dominating the global digital PCR market share due to the presence of major players, the prevalence of cancer, and the well-established infrastructure in the market. In addition, the region is dominating the market due to the high patient population awareness of novel diagnostic choices and the availability of modern dPCR devices in the area. Furthermore, the digital PCR market expansion in the region is being driven by the increasing prevalence of numerous cancers and metabolic illnesses that call for cutting-edge diagnostics and treatments.
However, the Asia Pacific region is anticipated to grow over the next few years of global digital PCR market owing to ongoing development and modernization of the healthcare infrastructure in developing Asian nations, the rise in the number of genomics and oncology research projects in China, India, and Japan, the trend of major pharmaceutical companies outsourcing clinical research to CROs in Asia, and ongoing government support for genomics-based research activities in developing Asia Pacific nations.
LIST OF KEY COMPANIES PROFILED:
· Avance Biosciences
· Bio-Rad Laboratories, Inc.
· JN Medsys
· Merck KGaA
· Precigenome LLC
· QIAGEN
· Standard BioTools
· Stilla
· Sysmex Corporation
· Thermo Fisher Scientific
· Others
Key Developments:
August 2022- Bio-Rad Laboratories acquired Curiosity Diagnostics to bring a new generation of rapid PCR systems to market.
July 2022- QIAGEN announced the launch of a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers, particularly those involved in the biopharma industry.
April 2022- Stilla has made a co-marketing agreement with Promega Corporation to offer complete dPCR solution which combines sample preparation with the latest Maxwell systems and digital PCR on the six-color naica system. It will offer an optimized workflow for a wide range of applications including liquid biopsy, sentinel pathogen testing, infectious disease assays, overall cancer research and drug discovery.
January 2022- JN Medsys develops a PCR test kit that specifically detects the Omicron variant with high accuracy.
August 2018- Merck Introduced BioReliance Droplet Digital Polymerase Chain Reaction (ddPCR) technology for tittering viral products, including recombinant Adenovirus, Adeno-Associated Virus, Lentivirus and Retrovirus and other vectors used in cell and gene therapy development.
SEGMENTATION
By Type
- Droplet Digital PCR
- Chip-based Digital PCR
- Others
By Product
- Software and Services
- Instruments
- Reagents & Consumables
By End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Industries
- Research Laboratories and Academic Institutes
- Diagnostic Centres
- Clinical Research Organizations
- Forensic Laboratories
By Region
- North America- U.S., Mexico, Canada
- Europe- UK, France, Germany, Italy, Spain, Rest of Europe
- Asia-Pacific- China, Japan, India, South Korea, Rest of Asia Pacific
- South America- Brazil, Argentina, Colombia, Rest of South America
- The Middle East and Africa- GCC, South Africa, Rest of Middle East & Africa
ARE YOU SEEKING COMPREHENSIVE INSIGHT ON VARIOUS
MARKETS?
CONTACT OUR EXPERTS TODAY
Speak to an Expert
Digital PCR Market Size
- August-2022
- 148
- Global
- healthcare-medical-devices-biotechnology
Related Research
2022-2030 Global and Regional B-Cell Non-Hodgkin`s Lymphoma (NHL) Treatment Industry Production, Sa
February-2021
2022-2030 Global and Regional Organ Transplant Diagnostics Industry Production, Sales and Consumpti
February-2021
2022-2030 Global and Regional Prostacyclin Drug Industry Production, Sales and Consumption Status a
February-2021
2022-2030 Global and Regional Spinal and Bulbar Muscular Atrophy Treatment Industry Production, Sal
February-2021
2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status & Trend Report 2022-2030 Top 20 Countri
April-2021
2021-2027 Global and RegioAnal Nasal Gels Industry Production, Sales and Consumption Status and Pros
February-2021
2021-2027 Global and Regional 2019-nCoV Detection Server Industry Production, Sales and Consumption
February-2021
2021-2027 Global and Regional ? Collagen Quantitative Determination Kit Industry Production, Sales a
February-2021
2021-2027 Global and Regional Anti-TNF Monoclonal Antibody Industry Production, Sales and Consumptio
February-2021